{
    "Trade/Device Name(s)": [
        "Instant View\u00ae Multi-Drug of Abuse Urine Test Cup",
        "Instant View\u00ae Multi-Drug of Abuse Urine Test Panel"
    ],
    "Submitter Information": "Alfa Scientific Designs, Inc.",
    "510(k) Number": "K131645",
    "Predicate Device Reference 510(k) Number(s)": [
        "K063545"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKZ",
        "DIS",
        "JXM",
        "DJC",
        "DJG",
        "DJR",
        "LCM",
        "LFG",
        "LDJ",
        "DIO"
    ],
    "Summary Letter Date": "September 23, 2013",
    "Summary Letter Received Date": "September 24, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3650",
        "21 CFR 862.3620",
        "21 CFR 862.3910",
        "21 CFR 862.3870"
    ],
    "Regulation Name(s)": [
        "Amphetamine Test System",
        "Barbiturate Test System",
        "Benzodiazepine Test System",
        "Cocaine and Cocaine Metabolite Test System",
        "Methamphetamine Test System",
        "Opiate/Morphine Test System",
        "Cannabinoid Test System",
        "Tricyclic Antidepressant Drugs Test System",
        "Phencyclidine Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Barbiturates",
        "Benzodiazepine",
        "Cocaine",
        "MDMA",
        "Methamphetamine",
        "Methadone",
        "Morphine",
        "Oxycodone",
        "Phencyclidine",
        "Tricyclic antidepressants",
        "Marijuana"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow chromatographic immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Panel",
        "Cup"
    ],
    "Document Summary": "FDA 510(k) summary for Instant View Multi-Drug of Abuse Urine Test Cup and Panel for qualitative detection of multiple drugs of abuse using lateral flow immunoassay technology in urine.",
    "Indications for Use Summary": "Rapid, qualitative, over-the-counter immunoassay for detecting one or more listed drugs or drug metabolites in human urine at or above specified cut-off levels; provides preliminary results requiring confirmation by alternative chemical methods.",
    "fda_folder": "Toxicology"
}